Skip to main content

GSA CAPITAL PARTNERS LLP

Position in NBIX — Neurocrine Biosciences Inc

CIK 1362033 LONDON, X0

Position in NBIX

as of Mar 31, 2026 · filed May 8, 2026
Position Value
$881,077
+$345,811 QoQ
Shares Held
6,688
+77.2% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
14 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

GSA CAPITAL PARTNERS LLP holds $10,107,066 across 16 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (8.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 NBIX
Neurocrine Biosciences Inc
This page
6,688 $881,077

All Filings in NBIX

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $881,077 6,688
2025-12-31 $535,266 3,774
2025-09-30 $335,087 2,387
2025-03-31 $294,970 2,667
2024-09-30 $1,000,340 8,682
2024-06-30 $220,822 1,604
2023-09-30 $220,950 1,964
2023-06-30 $230,657 2,446
2022-12-31 $1,455,854 12,189
2022-09-30 $403,916 3,803
2022-06-30 $499,682 5,126
2021-09-30 $468,999 4,890
2020-09-30 $680,908 7,081
2020-06-30 $203,252 1,666